Charles River Laboratories International (CRL) Long-Term Investments (2010 - 2026)

Charles River Laboratories International's Long-Term Investments history runs 9 years deep, the most recent figure standing at $207.0 million for Q4 2025.

• In Q4 2025, Long-Term Investments fell 5.21% year-over-year to $207.0 million; the TTM figure through Dec 2025 stood at $207.0 million (down 5.21% YoY), while the FY2025 annual figure was $207.0 million, down 5.21% from the prior year.
• Long-Term Investments for Q4 2025 stood at $207.0 million, up from $194.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $218.4 million in Q4 2024, with the low at $51.7 million in Q4 2021.
• The 5-year median for Long-Term Investments is $151.2 million (2022), against an average of $150.3 million.
• The sharpest annual moves came in 2021 and 2022: Long-Term Investments sank 73.76% in 2021, then surged 253.09% in 2022.
• Charles River Laboratories International's Long-Term Investments stood at $51.7 million in 2021, then soared by 253.09% to $182.6 million in 2022, then plunged by 33.64% to $121.2 million in 2023, then soared by 80.22% to $218.4 million in 2024, then dropped by 5.21% to $207.0 million in 2025.
• Business Quant data shows CRL's Long-Term Investments at $207.0 million in Q4 2025, $194.6 million in Q3 2025, and $216.1 million in Q2 2025.